Wedelolactone (IKK Inhibitor II) is a naturally occuring coumarin ether with potent hepatoprotective activities. Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway. Wedelolactone suppresses cell proliferation and migration through AKT and AMPK signaling in melanoma. Wedelolactone Enhances Odontoblast Differentiation by Promoting Wnt/β-Catenin Signaling Pathway and Suppressing NF-κB Signaling Pathway.

纯度：≥98%

CAS：524-12-9